RSS

vaccines

A decision by Public Health England to not publish the results of three clinical trials into vaccines for children has been criticised by scientist more

News

A record high in the number of cases of measles in the European Region has been revealed by the World Health Organisation (WHO), leading to calls for immediate action to stop the further spread of the disease. more

News

Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). more

News

Manufacturer of egg-based influenza vaccines in the UK, Seqirus, has revealed it is joining the Human Vaccines Project’s Universal Influenza Vaccine Initiative (UIVI) — a collaborative effort to accelerate the development of a universal flu vaccine more

News

The UK’s technology innovation provider for process manufacturing, the Centre for Process Innovation (CPI), has announced its involvement in the development of a new research hub aimed at delivering high-quality vaccines at low cost to tackle the spr more

News

Emergex Vaccines Holding (Emergex) — a biotechnology company — has been awarded with a grant of £979,318 from Innovate UK to progress its universal flu vaccine programme through preclinical development. more

News

Wacker Chemie has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, from SynCo Bio Luxembourg, doubling Wacker Biotech’s overall capacity and strengthening the company’s pharma-protein business more

News

In this online exclusive, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), looks at the importance of vaccines in the fight against antimicrobial resistance (AMR). more

Opinion

We speak with the CEO of Controlant, Gisli Herjolfsson, about the company and its cold chain solutions that are revolutionising delivery of vaccines to developing countries and more. more

Opinion

UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an expansion for the immune-oncology R&D team more

News

The World Health Organisation (WHO) has released figures highlighting a startling 400% increase in cases of measles reported in 2017 compared with the previous year’s figures. more

Analysis

Through identifying the way skin reacts to pathogens in older patients, a team of researchers from University College London (UCL) have found that blocking inflammation may help improve vaccine efficacy. more

News

Batavia Biosciences is partnering with an international consortium, coordinated by international non-profit organisation, PATH, to develop and manufacture safer novel oral poliovirus vaccines (nOPV). more

News

Researchers at the University of California, Berkeley, have developed a small device that administers vaccines through the inside of the cheek without pain or the need for a professional. more

Home

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News

The University of Manchester has been given £177,713 to fund the development of a Zika virus vaccine as part of an initiative to counter the disease more

News

Sanofi is to partially fund the Human Vaccines Project, a non-profit partnership aiming to solve the primary problems impeding vaccine/immunotherapy development more

News

The European AIDS Vaccine Initiative 2020 (EAVI2020) has launched with a £16 million initiative to accelerate the search a HIV vaccine more

News

ELC’s Dr Parvinder Punia and Dr Siddharth Chachad discuss global and regional vaccine programmes more

, Opinion

A minimally invasive vaccine that combines cancer cells and immune-enhancing factors promises to “launch a destructive attack” on tumors more

News